European Archives - Page 283 of 1154 - European Medical Journal

FDA nod for world's first needle-free allergic reaction treatment

The FDA has granted approval for an innovative epinephrine nasal spray, making it the first needle-free emergency treatment for potentially fatal allergic reactions.

Upgrading the US congress customer experience

A US congress is the place to put your drug on the map, but is this landscape the home of great customer experience for HCPs?

Astellas’ Tadaaki Taniguchi on how to challenge the status quo

In this season finale of the podcast, Isabel speaks to Dr Tadaaki Taniguchi, Chief Medical Officer, Head of Medical and Development, Astellas Pharma.

Stress Diminishes Cognitive Reserve's Protective Role in Dementia

Recent research from the Karolinska Institutet in Stockholm has shed light on the complex relationship between cognitive reserve and stress.

Myotonia: Are We Underestimating the Burden in Myotonic Disorders?

‘Raising awareness of the burden of disease due to myotonia will enhance understanding of patients’ needs, and improve the management…

EMJ Neurology 12.1 2024

A feature calling for a biological definition for Parkinson’s disease, and an article highlighting the importance of early recognition…

Interview: Tom Davenport

For clinical applications of AI, it’s still early; most are unlikely to be found at the patient’s bedside and are still in the research…

Listen To Those Living With PBC

Take a listen to this series of short videos that cover the personal experiences and challenges faced by those living with primary…

Review of the 10th European Academy of Neurology (EAN) Congress

THE 10th anniversary Congress of the European Academy of Neurology (EAN) in Helsinki, Finland, marked a significant milestone in European…

Reimagining Myasthenia Gravis Care

Myasthenia gravis (MG) is an autoimmune disease caused by autoantibodies targeting proteins on the neuromuscular junction. Around 85%…